pSEVA421-Cas9tr Citations (1)

Originally described in: Recombination-Independent Genome Editing through CRISPR/Cas9-Enhanced TargeTron Delivery.
Velazquez E, Lorenzo V, Al-Ramahi Y ACS Synth Biol. 2019 Sep 20;8(9):2186-2193. doi: 10.1021/acssynbio.9b00293. Epub 2019 Sep 3. PubMed Journal

---

Articles Citing pSEVA421-Cas9tr

Articles
CRISPR/Cas9-enhanced Targetron Insertion for Delivery of Heterologous Sequences into the Genome of Gram-Negative Bacteria. Velazquez E, Al-Ramahi Y, de Lorenzo V. Curr Protoc. 2022 Sep;2(9):e532. doi: 10.1002/cpz1.532. PubMed

If you have published an article using this material, please email us at to have your article added to this page.